publication date: Apr. 25, 2016

AACR 2016 – In Brief

Nancy Davidson Begins Term as AACR President; Weinberg Receives Lifetime Achievement Award 

 

NANCY DAVIDSON was inaugurated as president of the American Association for Cancer Research for 2016-2017 at the association’s annual meeting in New Orleans.

Davidson is the director of the University of Pittsburgh Cancer Institute. She also serves as associate vice chancellor for cancer research; the Hillman professor of oncology; a distinguished professor of medicine and pharmacology and chemical biology; and a professor in the Clinical and Translational Science Institute at the University of Pittsburgh School of Medicine. Her research focuses on clinical and translational breast cancer research and cancer biology and treatment.

José Baselga, physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center in New York, now serves as AACR past president.

Davidson is known for her studies involving the role of hormones and the estrogen receptor in breast carcinogenesis that have defined the molecular mechanisms driving the disease as well as for her efforts to establish novel therapeutic approaches for patients who fail to respond to common treatment modalities. She has led clinical trials involving chemotherapy and endocrine-related therapies for treating premenopausal breast cancer and optimal chemotherapy for early breast cancer.

Davidson has been actively involved in the AACR since 1988 and was elected to the AACR board of directors. She is an editorial board member of Cancer Prevention Research and has served on numerous other boards and committees, including: the AACR Distinguished Lectureship in Breast Cancer Research Award Committee; chair … Continue reading 42-16 Nancy Davidson Begins Term As AACR President

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.